Page last updated: 2024-08-16

probenecid and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

probenecid has been researched along with 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taylor, CP; Vartanian, MG1
Hansen, KT1
Löscher, W; Löschmann, PA; Richter, A1

Other Studies

3 other study(ies) available for probenecid and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

ArticleYear
Probenecid pretreatment enhances anticonvulsant action of NBQX in mice.
    European journal of pharmacology, 1992, Mar-17, Volume: 213, Issue:1

    Topics: Animals; Anticonvulsants; Ataxia; Drug Synergism; Injections, Intravenous; Male; Mice; Motor Activity; Probenecid; Quinoxalines; Seizures

1992
Hepatic uptake and biliary excretion of the neuroprotectant 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo-(F)-quinoxaline in rat liver. Involvement of an organic anion transport system.
    Biochemical pharmacology, 1995, Feb-14, Volume: 49, Issue:4

    Topics: Animals; Bile; Biological Transport; Dose-Response Relationship, Drug; Liver; Male; Perfusion; Probenecid; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA

1995
The AMPA receptor antagonist NBQX exerts antidystonic effects in an animal model of idiopathic dystonia.
    European journal of pharmacology, 1993, Feb-09, Volume: 231, Issue:2

    Topics: Animals; Cricetinae; Dystonia; Electric Stimulation; Excitatory Amino Acid Antagonists; Female; Injections, Intraperitoneal; Male; Mesocricetus; Probenecid; Quinoxalines; Receptors, AMPA; Solutions; Suspensions

1993